Mackenzie Financial’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-109,754
| Closed | -$1.64M | – | 938 |
|
2016
Q2 | $1.64M | Buy |
109,754
+29,600
| +37% | +$443K | 0.01% | 484 |
|
2016
Q1 | $975K | Sell |
80,154
-120,400
| -60% | -$1.46M | 0.01% | 513 |
|
2015
Q4 | $3.19M | Buy |
200,554
+9,100
| +5% | +$145K | 0.02% | 349 |
|
2015
Q3 | $2.94M | Sell |
191,454
-1,500
| -0.8% | -$23K | 0.02% | 349 |
|
2015
Q2 | $4.69M | Sell |
192,954
-40,600
| -17% | -$987K | 0.03% | 312 |
|
2015
Q1 | $5.43M | Buy |
233,554
+6,954
| +3% | +$162K | 0.03% | 311 |
|
2014
Q4 | $5.69M | Buy |
226,600
+1,800
| +0.8% | +$45.2K | 0.03% | 304 |
|
2014
Q3 | $6.99M | Sell |
224,800
-4,600
| -2% | -$143K | 0.04% | 281 |
|
2014
Q2 | $5.93M | Sell |
229,400
-82,800
| -27% | -$2.14M | 0.03% | 308 |
|
2014
Q1 | $7.3M | Buy |
312,200
+31,900
| +11% | +$745K | 0.04% | 280 |
|
2013
Q4 | $7.11M | Buy |
+280,300
| New | +$7.11M | 0.04% | 268 |
|